TrialBMC neurology2018

Results of a randomized, double blind, placebo controlled, crossover trial of melatonin for treatment of Nocturia in adults with multiple sclerosis (MeNiMS).

Marcus J Drake et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.